|
Volumn 65, Issue 1, 2012, Pages 1-2
|
Should minimization replace randomization in all clinical trials?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA TOCOPHEROL;
OMEGA 3 FATTY ACID;
ALGORITHM;
CARDIOVASCULAR DISEASE;
CITATION ANALYSIS;
CLINICAL ASSESSMENT;
CLINICAL PRACTICE;
CLINICAL TRIAL (TOPIC);
COMORBIDITY;
DIABETES MELLITUS;
DIAGNOSTIC ACCURACY;
DISEASE CONTROL;
DOCTOR PATIENT RELATION;
EDITORIAL;
EPIDEMIOLOGICAL DATA;
HEALTH CARE PERSONNEL;
HEALTH PROMOTION;
HEALTH STATUS;
HUMAN;
HYPERTENSION;
MEDICAL RECORD;
MORBIDITY;
MORTALITY;
NUTRITION;
OBSERVATIONAL STUDY;
PATIENT SELECTION;
PRIORITY JOURNAL;
PSYCHOMETRY;
QUESTIONNAIRE;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RANK MINIMIZATION ANALYSIS;
SHORT FORM 36;
STATISTICAL ANALYSIS;
SYSTEMATIC REVIEW (TOPIC);
TREATMENT INDICATION;
ALGORITHMS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
MODELS, STATISTICAL;
RANDOM ALLOCATION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
SAMPLE SIZE;
SELECTION BIAS;
|
EID: 82255164352
PISSN: 08954356
EISSN: 18785921
Source Type: Journal
DOI: 10.1016/j.jclinepi.2011.10.011 Document Type: Editorial |
Times cited : (1)
|
References (1)
|